Use our HBOC Research Search tool to find and participate in research focused on hereditaty cancers. Need assistance getting started?
Women who are at increased risk of ovarian cancer who:
Patients are excluded if they:
Quality of Life:
High Risk But No Cancer
Sites are enrolling in Chicago, IL; Boston, MA; Rochester, MN; New York, NY; Houston, TX; Seattle, WA. For more information you can contact the study by email.
The goal of the WISP Study is to compare whether removal of fallopian tubes only, delaying removal of the ovaries can safely improve sexual functioning and menopausal symptoms compared to standard risk-reducing removal of the ovaries and fallopian tubes (also known as risk-reducing salpingo-oophorectomy or RRSO).
This is a non-randomized study. Women who participate in this study will be able to choose which type of ovarian procedure they wish to undergo:
Removal of the ovaries and fallopian tubes (also known as Risk-Reducing Salpingo-Oophorectomy or RRSO) is the recommended way for high-risk patients with certain types of genetic mutations to lower their risk for ovarian cancer. With RRSO the fallopian tubes and ovaries are removed at the same time and women who have not yet reached menopause may experience symptoms and long-term side effects of early-onset menopause. New research suggests that many ovarian cancers may actually begin in the fallopian tubes leading patients and researchers to wonder if they could keep the ovaries until closer to natural menopause and still lower their risk by removing the fallopian tubes (with or without one ovary) only, followed by ovarian removal several years later.
The goal of this clinical research study is to compare the changes in female sexual function between patients having interval salpingectomy with delayed oophorectomy (ISDO) with those having risk-reducing salpingo-oophorectomy (RRSO) in women who carry genetic mutations. Researchers also want to learn how these surgeries affect your quality of life.
ISDO is surgery to remove the fallopian tubes first, then the ovaries are removed during a second, later surgery. Most women with genetic mutations will be encouraged to remove the ovaries around the ages of 40 to 50. The decision in timing to remove your ovaries will be made with your doctor.
You can visit the WISP website for more information.
Principal Investigator: Karen H. Lu, MD M.D. Anderson Cancer Center
The following sites are enrolling: